OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Editorial Board	51
A novel antiviral strategy by disrupting the equilibrium of virus-host calcium homeostasis	50
Inhaled aerosol viral-vectored vaccines against tuberculosis	38
Transmission patterns of hepatitis E virus	35
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	35
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	34
The enigmatic roles of Anelloviridae and Redondoviridae in humans	34
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	31
Human placental models for studying viral infections	30
Editorial Board	30
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	27
Editorial overview: Viral pathogenesis	25
Editorial Board	24
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	23
Emerging technologies in the study of the virome	23
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface	22
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	20
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	20
A complex immune communication between eicosanoids and pulmonary macrophages	20
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	19
Asymmetry in icosahedral viruses	19
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	18
Editorial Board	18
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	18
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	17

Tissue-resident memory T cells in protective immunity to influenza virus	17
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	17
Oncogenic Animal Herpesviruses	17
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	17
Retasking of canonical antiviral factors into proviral effectors	17
Human organoid models to study coronavirus infections of the respiratory tract	17
Deimmunization of flagellin adjuvant for clinical application	16
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions	16
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	16
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection	16
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	16
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	15
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	15
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	15
Antigenic evolution of SARS coronavirus 2	14
Sequence variability of the K1 gene in Kaposi’s sarcoma-associated herpesvirus and its role in pathogenesis	14
Modeling zoonotic and vector-borne viruses	14
Broadly neutralizing antibodies against COVID-19	13
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	13
Editorial Board	12
Editorial Board	11
Human autoantibodies against type I interferons in severe viral disease	11
Early signaling pathways in virus-infected cells	11
Antiviral restriction factors of bats: the front line of a critical reservoir of zoonotic viruses	10
Editorial overview: Special issue on phage therapy	10
Structural insights into hepatitis C virus neutralization	10
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	10
Editorial overview: Virus structure and expression	9
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	9
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	9
Predisposition to viral infection of the fetus and neonate	9
Lying low-chromatin insulation in persistent DNA virus infection	8
Koala retrovirus and neoplasia: correlation and underlying mechanisms	8
Editorial Board	8
Clinical and mechanistic insights into Brucella and viral co-infection	8
Editorial Board	7
Host-targeted antivirals as broad-spectrum inhibitors of respiratory viruses	7
Editorial overview: Antiviral Strategies and Counter Measures (2025)	7
Editorial Board	6
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	6
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	6
New directions in the multifunctionality of RNA viruses: insights from the rabies virus P-protein	5
Ex vivo culture models to study viral infections of the liver	5
The role of human lipoproteins for hepatitis C virus persistence	5
Bridging the gap: ex vivo human skin explants for mechanistic studies of arboviruses	5
A comparative review of adenovirus A12 and C5 oncogenes	5
Beyond the liver: the broadened tissue tropism of hepatitis E virus	5
Editorial Board	5
Therapeutic approaches to Epstein–Barr virus cancers	5
Proteomic analysis of antiviral innate immunity	4

Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection	4
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology	4
Viral determinants influencing intra- and intercellular communication in cytomegalovirus infection	4
Pathogenesis of severe acute respiratory syndrome coronavirus-2 in nonhuman primates	4